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Abstract
A key aspect of bacterial survival is the ability to evolve while migrating across spatially varying 
environmental challenges. Laboratory experiments, however, often study evolution in well-mixed 
systems. Here we introduce an experimental device, the Microbial Evolution and Growth Arena 
(MEGA) plate, in which bacteria spread and evolve on a large antibiotic landscape (120x60cm), 
allowing visual observation of mutation and selection in a migrating bacterial front. While 
resistance increases consistently, multiple coexisting lineages diversify both phenotypically and 
genotypically. Analyzing mutants at and behind the propagating front, we find that evolution is not 
always led by the most resistant mutants; highly resistant mutants may be trapped behind more 
sensitive lineages. The MEGA-plate provides a versatile platform for studying microbial adaption 
and a direct seeing-is-believing visualization of evolutionary dynamics.
Main Text
The worldwide increase in antibiotic resistance has motivated numerous studies aimed at 
understanding the phenotypic and genotypic evolution of antibiotic resistance (1–7). These 
experiments have shed light on the tradeoffs constraining adaptive evolution in single and 
multi-drug environments (5, 6, 8, 9). However, most of our current knowledge about the 
evolution of resistance is based on laboratory setups with well-mixed environments (1–7, 10, 
11).
In natural and clinical settings, bacteria migrate between spatially distinct regions of 
selection (5, 6, 8, 9, 12, 13). Theoretical models show that spatially structured pressures 
change the nature of selection: instead of competing with its neighbors for limited resources, 
an adapted individual needs only be the first capable of venturing and surviving in a new 
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region (14, 15). A pioneering study, focusing on small population sizes, showed that 
structured microenvironments increase the rate of adaptation to antibiotics through highly 
reproducible genetic changes (16). It is unknown how evolution is shaped by the 
diversification potential and differences in adaptive constraints of large populations in spatial 
environments.
Here, we present a device for the evolution of bacteria that allows migration and adaptation 
in a large, spatially structured environment. The Microbial Evolution and Growth Arena 
(MEGA) plate consists of a rectangular acrylic dish (120 x 60 cm) in which successive 
regions of black-colored agar containing different concentrations of antibiotics are overlaid 
by soft agar allowing bacterial motility (Fig. 1A). Motile bacteria inoculated at one location 
on the plate deplete nutrients locally and then spread by chemotaxis to other regions (17). 
Only increasingly resistant mutants can spread into sections containing higher levels of 
antibiotic. The large size of the plate serves two purposes: it provides for a large population 
and mutational supply, and it maintains the antibiotic gradient despite diffusion (since drug 
diffusion time scales quadratically with distance while the bacterial front advances linearly, 
the large plate size prevents the antibiotic gradient from equilibrating over the duration of 
the experiment). Critically, once a mutant has exhausted the resources of a region of the 
plate, other mutants do not significantly chemotax to that region (since, without a nutrient 
gradient, they move diffusively). In this manner, mutational lineages can block each other 
physically, a phenomenon notably observed in biofilm formation (18). This partitioning of 
mutants into stable spatial domains also enables sampling of individual mutants for later 
analysis. Using periodic photography of the plate we constructed time-lapse movies of 
evolution (movie S1). Combining these with analysis of isolates, this system allows 
reconstruction of the phenotypic and genotypic evolutionary histories of evolving bacteria.
Challenging bacteria in spatial gradients of antibiotics leads to large increases in resistance 
through sequential adaptive steps across competing lineages (Fig. 1; movie S1). We first set 
up the MEGA-plate with symmetric four-step gradients of trimethoprim (TMP) or 
ciprofloxacin (CPR) proceeding inwards with tenfold increases in concentration per step 
(Fig. 1A, TMP: 0, 3, 30, 300, 3000x wild-type Minimum Inhibitory Concentration, MIC; 
CPR: 0, 20, 200, 2000, 20000x MIC) and inoculated the drug free regions with Escherichia 
coli. Bacteria swim and spread until they reach a concentration in which they can no longer 
grow (TMP: Fig. 1C and movies S1 and S2; CPR: movie S3). As resistant mutants arise in 
the population, their descendants migrate into the next step of drug concentration and fan out 
(Fig. 1C, 88h). Adjacent mutant lineages exclude each other and compete for limited space, 
resulting in some lineages entirely blocking off growth of others (Fig. 1C). When the 
winning lineages reach a further increased level of drug concentration at which they, too, are 
unable to grow, secondary mutations arise, and the process repeats. Ultimately, the bacteria 
reach and overspread the highest drug concentration, showing dramatic increases in drug 
resistance (phenotyping sampled mutants from the highest concentration region showed 
10,000-fold increase in MIC for TMP, Fig. 1B; 100,000-fold increase for CPR, fig. S1). The 
adaption time (10 days in TMP; 12 days in CPR) is consistent with evolution in well mixed 
environments (4), yet is slower than reported adaptation rates in micro-spatial environments, 
likely a result of the additional time required to swim between concentration steps (9). It is 
possible that at different dimensions the MEGA-plate will yield different evolutionary 
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dynamics; a wider front would increase the effective population size and thus the mutational 
supply, while a longer run between steps would increase selection among adjacent lineages.
To test the importance of the size of intermediate steps in the evolution of high-level 
resistance, we set up a variant of the MEGA-plate in which bacteria go from no drug to a 
high level directly or through one middle region of variable magnitude (Fig. 2. TMP: high 
step 3000; middle step 0, 3, 30, or 300 MIC. CPR: high step 2000; middle step 0, 2, 20, or 
200 MIC). Bacteria were unable to adapt directly from zero to the highest concentration of 
either drug. Diffusive smoothing of these large steps enabled the appearance of partially 
resistant mutants, but their lineages did not advance (Fig. 2A, left). The addition of an 
intermediate concentration step enabled adaptation, although this was impeded when this 
middle step was too high (Fig. 2B). Even across the permissive intermediate steps, evolution 
often proceeded through multiple mutations taking advantage of the local gradients formed 
by diffusion (TMP: movie S4, CPR: movie S5). Thus, by progressing through colonization 
of regions with moderately challenging selective pressures, intermediate-resistance mutants 
can expand to sufficient numbers to facilitate the rise of high-resistance mutants. Analogous 
to evolutionary rescue in temporal selective gradients (19–21), a gradual spatial gradient 
allows adaptation to previously inhospitable environments. Unlike in a temporal gradient, 
though, a spatial gradient does not impose a minimal time for a mutant’s appearance and 
spread; at any time, a mutant appearing on the stalled front can expand and evolve further, 
provided it is sufficiently resistant to colonize the next step. Thus, concordant with 
theoretical predictions (22, 23), access to intermediate regions of moderate selection is 
critical for enabling a range of evolutionary paths to high-level resistance.
We next focused on the genotypic and phenotypic paths leading to high levels of resistance. 
We sequenced 21 isolates from the four-step TMP gradient experiment and 230 isolates from 
the multiple intermediate-step TMP experiment above. Samples separated into minimally 
and highly mutated, i.e. mutator phenotype, groups (>60 single nucleotide polymorphisms 
[SNPs] and indels for high; <12 for low; Fig. 3A). Similar separation was also seen when 
restricting the analysis to synonymous mutations to minimize differential effects of selection 
(fig. S2). All highly mutated isolates, but none of the others, had mutations in dnaQ (also 
called mutD), which was the only gene for which the presence of a mutation correlated 
perfectly with the mutator phenotype. This gene encodes DNA polymerase III which is 
critical to proofreading (22, 23). Isolates carrying mutated dnaQ alleles showed increased 
rates of mutations on rifampin disk diffusion assays (fig. S2)(24). These mutators appeared 
repeatedly in distinct locations on the plate and across experiments. Based on lineage 
reconstructions from the time-lapse video as well as genotypic relationships, the mutator 
phenotype emerged at least six times independently between the four-step and intermediate-
step TMP experiments above (fig. S2; four different alleles of dnaQ were observed: V96E, 
I97N, I97S, I97T, where I97T appeared three independent times). While these mutator 
lineages accumulated mutations more rapidly, their rate of phenotypic adaption was similar 
to that of the less mutated isolates (reaching the highest level of resistance at roughly the 
same time, fig. S3 and movie S4). Indeed, the highly mutated lineages had a close to neutral 
ratio of non-synonymous to synonymous substitutions (Fig. 3B). In contrast, the less 
mutated isolates showed a high bias towards coding mutations, indicating that most of these 
mutations were likely adaptive (Fig. 3B).
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Focusing on the non-mutator isolates, we identified a wide spectrum of putatively adaptive 
mutations for trimethoprim resistance. The most frequently mutated gene was the primary 
target of trimethoprim, folA (25), which encodes dihydrofolate reductase (DHFR) (Fig. 3C), 
with more mutations appearing as resistance increased. We also observed several genes that 
were repeatedly mutated yet are not involved in the folate biosynthesis pathway, and thus not 
primarily associated with trimethoprim resistance. These included stress response genes, 
such as those of the mar and sox operons, known to be important in general antibiotic and 
toxin resistance (26), as well as genes involved in transcription and translation, which have 
been shown to affect trimethoprim resistance (27). We also found that three genes not 
classically associated with trimethoprim resistance were repeatedly mutated, often with a 
probable loss of function (frameshift or nonsense): a phosphate transporter (pitA), shikimate 
kinase I (aroK), and a negative regulator of the PhoQP system (mgrB). Knockout of these 
genes in the ancestral strain confirmed their resistance phenotypes (fig. S4).
Mutations that increased resistance often came with a cost of reduced growth, which was 
subsequently restored by additional, compensatory, mutations (28–30). While some 
resistance-conferring mutations allowed colonization of high drug concentration regions 
without affecting growth, many lineages capable of growing in the high drug regions were 
deficient in yield, particularly during CPR resistance evolution (as measured by optical 
density, Fig. 4A–B, for CPR; fig. S3 for TMP). These yield deficient mutations were 
followed by compensatory mutations allowing growth to full density (Fig. 4A,B; movie S3; 
number of compensatory mutants observed in a single run: >50 for TMP and >500 for CPR). 
In the absence of a chemotaxis-inducing nutrient gradient, the compensatory mutants stayed 
localized behind the front – appearing in a characteristic pattern of localized spots spreading 
from single points (movie S3; Fig. 4A).
Focusing on evolution in CPR, we sampled and phenotyped compensatory mutants, finding 
that many had not only compensated for growth but had also increased in resistance, often 
beyond the resistance levels of the propagating front (Fig. 4C). Yet, as these mutants were 
engulfed by their parental lineage, they stayed constrained to the immediate vicinity in 
which they appeared and were unable to overtake the moving front. To test whether these 
compensatory mutants were capable of outcompeting the propagating front, in an additional 
evolution experiment we sampled the trapped compensatory mutants and moved them 
forward, re-inoculating them ahead of the still-moving front. These compensatory mutants 
were able to grow in a region where the front could not (Fig. 4D). Similarly, some trapped 
compensatory mutants were able to outcompete their parent when placed side-by-side on a 
fresh gradient plate (fig. S5). Hence, as compensatory mutations often occur behind the 
front, they are spatially restricted from contributing to the ultimate evolutionary course of 
the population. Indeed, in the rare cases when these compensatory mutations appeared at the 
front, and were not physically blocked, they accelerated the adaptive process (movie S3, 
00:53; fig. S3). Thus, the fitness of the population is not driven by the fittest mutants, but 
rather by those that are both sufficiently fit and arise sufficiently close to the advancing 
front.
While the MEGA-plate is not intended to directly simulate natural or clinical settings, it 
captures unique aspects of evolution during range expansion. Evolution of high levels of 
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resistance is enabled by intermediate regions of moderate selective pressure. Furthermore, as 
multiple lineages evolve in parallel, the propagating front can be led by lineages less fit than 
those trapped behind it.. It will be interesting to explore how adaptation rates and mutational 
diversity depend on other spatio-temporal parameters, including population density, 
mutation rate, and the relative expansion speed and spatial dimensions. Owing to the relaxed 
evolutionary constraints in range-expansion dynamics, the MEGA-plate is likely to reveal 
novel mutational pathways to high-level multi-antibiotic resistance. Further, the MEGA-
plate can be adapted to a range of organisms and challenges beyond antibiotics. Importantly, 
differences in evolutionary dynamics between evolution under different selection pressures 
appear visually, simplifying both hypothesis generation and testing. Owing to this flexibility, 
the MEGA-plate is a platform for exploring the interplay of spatial constraints and 
evolutionary pressures. The MEGA-plate provides a physical analog of the otherwise 
abstract Muller plots of population genetics (31, 32) and of other elusive aspects of 
evolution, including diversification, compensatory mutations, and clonal interference. Its 
relative simplicity and ability to visually demonstrate evolution makes the MEGA-plate a 
useful tool for science education and outreach.
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Fig. 1. An experimental device for studying microbial evolution in a spatially structured 
environment
(A) Setup of the four-step gradient of Trimethoprim (TMP). Antibiotic is added in sections 
to make an exponential gradient rising inwards. (B) The four-step TMP MEGA-plate after 
12 days. E. coli appear as white on the black background. The 182 sampled points of clones 
are indicated by circles, colored by their measured MIC. Lines indicate video-imputed 
ancestry. (C) Time-lapse images of a section of the MEGA-plate. Repeated mutation and 
selection can be seen at each step. Images have been aligned and linearly contrast-enhanced 
but are otherwise unedited.
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Fig. 2. Initial adaptation to low drug concentrations facilitates later adaptation to high 
concentrations
(A) Frames from a section of the TMP intermediate step MEGA-plate over time (TMP, 
movie S4; CPR, movie S5). The first frame showing a mutant in the highest band is 
indicated by a blue box. (B) The rates of adaptation in the intermediate step experiments 
across TMP and CPR, showing the necessity of intermediate adaptation for the evolution of 
high levels of resistance. Error bars show the appearance times of multiple lineages in the 
highest concentration. As the intermediate step with no drug puts the highest and lowest 
concentrations adjacent, it serves as both the highest and lowest intermediate steps (dotted 
line).
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Fig. 3. Diverse genotypic strategies for adaptation to trimethoprim
(A) The number of observed mutations across individual isolates. Samples with a dnaQ 
mutation (filled symbols) consistently carried more mutations than those sampled with the 
wild-type dnaQ allele (‘x’ symbols). Data points are horizontally jittered for clarity. (B) The 
normalized ratio of non-synonymous to synonymous substitutions of isolates compared with 
the ancestor for samples with normal and highly mutated phenotypes. Error bars are the 
standard deviation of the Bayesian posterior estimate for the binomial parameter. (C) The 
number of distinct mutational events in genes that were mutated at least twice independently. 
Genes are colored by pathway per EcoCyc (33). Non-synonymous, synonymous and loss of 
function (including indel and nonsense) are indicated by the fill. Genes that only had one 
mutation across all samples were combined into the “unique” column. Individual mutations 
events were inferred through ancestry (movies S1 and S4). Inset: The multi-step MEGA-
plate with samples containing the mutation soxR R20C (yellow) tracing mutational events 
from multiple samples and video.
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Fig. 4. Compensatory mutations can be spatially trapped
(A) Ciprofloxacin experiment still frame with locations of 24 isolates showing a full-fitness 
mutation (cyan) or yield-deficient mutation followed by a compensatory mutation (purple). 
(B) Optical density at the marked points in (A) over the course of the experiment. The two 
example traces (indicated by a square and triangle) correspond to the points marked by the 
same glyph in (A). (C) Mutants isolated behind the front can have significantly higher 
resistance than the front at the time it passed the same location. Resistance of the front was 
measured by the concentration at which front progression stopped, isolate MICs were 
measured in vitro. (D) The front (marked F), and three compensatory mutants (marked 1–3), 
were sampled at 162 hours, and immediately inoculated ahead of the front as indicated by 
the arrows. Growth of the moved mutants is evident for the three compensatory mutants, 
despite being inoculated at a CPR concentration dramatically higher than where they 
emerged, but not for the front. (E) Measured CPR MICs of the mutants from (D).
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